ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2015, Vol. 24 ›› Issue (6): 504-511.

• 论文 • 上一篇    下一篇

单克隆免疫球蛋白病相关C3肾炎的临床病理分析

  

  • 出版日期:2015-12-28 发布日期:2015-12-29

C3 glomerulonephritis associated with monoclonal gammopathy

  • Online:2015-12-28 Published:2015-12-29

摘要:

目的:了解单克隆免疫球蛋白病相关的C3肾炎的临床病理特征。
方法:回顾性分析2004年3月至2015年5月南京军区南京总医院肾脏科经肾活检病理诊断为C3肾炎的患者,筛选出血清免疫固定电泳见单克隆条带者,统计其临床及病理资料。
结果:(1)一般资料:C3肾炎患者共有38例,其中行血清免疫固定电泳检查者16例。血清单克隆免疫球蛋白阳性者7例,男性5例、女性2例,肾活检时年龄44~65岁,病程3~67月。肾脏损害临床表现为肾病综合征4例,多形型血尿者6例,血清肌酐升高3例,贫血4例。(2)补体及补体相关检查: C3下降4例,C4、血清H因子均正常,C3肾炎因子及抗H因子抗体均阴性(6/6)。(3)血液学检查:单克隆免疫球蛋白种类λ型IgG 3例,κ型IgG 2例,λ型IgA 1例, κ轻链 1例。血游离轻链比值异常2例。浆细胞升高2例(2/6)。(4)肾脏病理:7例免疫荧光均以C3沉积于肾小球毛细血管袢及系膜区,轻链染色阴性,光镜均呈膜增生样病变,2例伴新月体,肾小管间质病变较轻;电镜下电子致密物无特殊结构,主要沉积于内皮下及系膜区,2例内皮细胞病变明显。(5)治疗及随访:2例浆细胞异常的患者接受沙利度胺联合地塞米松治疗,其中1例肾脏病长期缓解,1例快速进展至终末期肾病;余5例患者接受雷公藤多苷和(或)糖皮质激素治疗,1例失随访,3例尿检改善,4例肾功能稳定。
结论:单克隆免疫球蛋白相关的C3肾炎好发于中老年患者,组织学以肾小球膜增生样病变为主,免疫抑制治疗有一定的疗效,但治疗的关键应针对单克隆免疫球蛋白病。

关键词: 单克隆免疫球蛋白, C3肾炎, 膜增生性肾小球肾炎病理

Abstract:

Objective:To explore the clinical and patholgical features of C3 glomerulonephritis(C3 GN) associated with monoclonal gammopathy from Chinese patients.
Methodology:From March 2004 to May 2015,patients who were diagnosed as C3 GN and meanwhile with a monoclonal immunoglobulin in serum were selected and their clinical and pathological features were retrospectively analyzed.
Results:Seven patients with C3 GN had evidence of a monoclonal immunoglobulin in serum. Patients were 5 males and 2 female with age 4465 years old.All of them had proteinuria with 104-734 g/d of urine protein excretion. Microscopic hematuriawas observed in 6 patients, elevated serum creatine(SCr) in 3 patientshypertension, hypertension in 6 patients, low serum complement C3 in 4 patients, and complement C4 was normal in all patients. No abnormalities were found for serum C3 nephritic factors(C3NeFs), Factor H and anti factor H antibody. The most common monoclonal gammopathy was IgG  λ(3 patients).Other gammopathies included IgG κ(2 patients), IgA λ(one patient), and light chain κ(one patient). Elevated plasma cells were observed in 2 of 6 patients. Membranoproliferative GN was presented in all patients. Two patients with abnormal plasma cells received Thalidomide plus Dexamethasone, of whom, one achieved a longtime complete remission in renal disease, and one had progression in kidney disease. The other 5 patients received either Tripterygium wilfordii and/or prednisone, of whom, one lost the followup, 4 had improvement in urine analysis,3 had stable renal function.
Conclusion:Monoclonal gammopathy was a predominant cause of C3 GN in the older patients. Pattern of pathological injury was membranoproliferative. Immunodepressive therapy may be effective, but the key point of therapy should be targeting monoclonal gammopathy.